Important Product Information, including Boxed WARNINGS, for ZORTRESS® (everolimus) Tablets, myfortic® (mycophenolic acid) delayed-release tablets, Neoral® (cyclosporine capsules, USP) MODIFIED, and SANDIMMUNE® (cyclosporine capsules, USP)
At Novartis, we're committed to helping people learn about their treatment—and helping patients access the medications they need. Explore useful information and prescription savings offers for ZORTRESS® (everolimus) Tablets, myfortic® (mycophenolic acid) delayed-release tablets, Neoral® (cyclosporine capsules, USP) MODIFIED, and SANDIMMUNE® (cyclosporine capsules, USP).
If eligible, you can take advantage of a $0 co-pay on your monthly refills.* Select from the options below to print a savings card.
*Limitations apply. See Program Terms and Conditions. This offer is not valid under Medicare, Medicaid or any other federal or state program. Limitations may apply to MA or CA residents. Patients may receive up to $7,200 in benefits per brand annually for the life of the program. If insured patient reaches the max annual cap per brand per calendar year of $7,200, patient will be responsible for the difference. This program is subject to termination or modification at any time.
Learn more about a 30-day trial on your first prescription.† Select from the options below to print your free trial voucher. For mobile users without access to a wireless printer, you can simply show your pharmacist an image of the voucher on your mobile device.
†One-time use only. All patients, regardless of the payer types, are eligible, including those with Medicare, Medicaid, or private insurance, and those without insurance coverage.
Important Product Information, including Boxed WARNINGS, for ZORTRESS, myfortic, Neoral, and SANDIMMUNE.